Table 3.
The top 10 enriched KEGG pathways of the down‐regulated genes
| Term | Count | P | Genes |
|---|---|---|---|
| Legionellosis | 4 | 6.26 × 10−4 | CXCL1, C3, CXCL2, CXCL8 |
| Pertussis | 4 | 0.001630681 | FOS, C3, CXCL8, C1S |
| Salmonella infection | 4 | 0.002182574 | CXCL1, FOS, CXCL2, CXCL8 |
| TNF signaling pathway | 4 | 0.004370617 | CXCL1, FOS, PTGS2, CXCL2 |
| Pathways in cancer | 6 | 0.006830986 | FOS, LAMA4, PTGS2, PGF, PDGFRA, CXCL8 |
| Leishmaniasis | 3 | 0.021059667 | FOS, PTGS2, C3 |
| PI3K–Akt signaling pathway | 5 | 0.021872858 | LAMA4, PGF, PDGFRA, IL3RA, DDIT4 |
| Antigen processing and presentation | 3 | 0.023923045 | KLRC2, KLRC3, CTSS |
| Chagas disease (American trypanosomiasis) | 3 | 0.042619701 | FOS, C3, CXCL8 |